Guillermo Drelichman

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

John D. Grainger, Franco Locatelli, Thirachit Chotsampancharoen et al. · The Lancet · 2015 · 206 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +13

Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy

Timothy M. Cox, Guillermo Drelichman, Renata Cravo et al. · Blood · 2017 · 90 citations · Full text

Clinical Consequences of Interrupting Enzyme Replacement Therapy in Children with Type 1 Gaucher Disease

Guillermo Drelichman, Elvira Ponce, Nora Basack et al. · The Journal of Pediatrics · 2007 · 55 citations

Type 1, Gaucher Disease, Clinical Consequences +4

Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study

Rodolfo Delfini Cançado, Nora Watman, Clarisse Lobo et al. · Hematology · 2018 · 15 citations · Full text

Long-term effect of imiglucerase in Latin American children with Gaucher disease type 1: lessons from the International Collaborative Gaucher Group Gaucher Registry

José Simon Camelo, Juan Francisco Cabello, Guillermo Drelichman et al. · BMC Hematology · 2014 · 13 citations · Full text